Sinopec Shanghai Petrochemical Valuation
Is 338 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 338 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 338 (HK$1.17) is trading above our estimate of fair value (HK$0.17)
Significantly Below Fair Value: 338 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 338?
Key metric: As 338 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 338's PS Ratio? | |
|---|---|
| PS Ratio | 0.1x |
| Sales | CN¥89.15b |
| Market Cap | CN¥26.04b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.1x |
| Enterprise Value/EBITDA | 20.3x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 338's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.3x | ||
1907 China Risun Group | 0.2x | 6.4% | HK$13.3b |
746 Lee & Man Chemical | 0.7x | n/a | HK$3.1b |
2198 China Sanjiang Fine Chemicals | 0.1x | n/a | HK$2.1b |
2881 Wuhan Youji Holdings | 0.1x | n/a | HK$471.2m |
338 Sinopec Shanghai Petrochemical | 0.1x | -3.1% | HK$28.0b |
Price-To-Sales vs Peers: 338 is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (0.3x).
Price to Sales Ratio vs Industry
How does 338's PS Ratio compare vs other companies in the HK Chemicals Industry?
Price-To-Sales vs Industry: 338 is good value based on its Price-To-Sales Ratio (0.1x) compared to the Hong Kong Chemicals industry average (0.4x).
Price to Sales Ratio vs Fair Ratio
What is 338's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.1x |
| Fair PS Ratio | 0.3x |
Price-To-Sales vs Fair Ratio: 338 is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | HK$1.16 | HK$1.24 +6.7% | 20.1% | HK$1.74 | HK$1.10 | n/a | 5 |
| Nov ’25 | HK$1.21 | HK$1.24 +2.3% | 20.1% | HK$1.74 | HK$1.10 | n/a | 5 |
| Oct ’25 | HK$1.20 | HK$1.25 +4.6% | 21.7% | HK$1.80 | HK$1.10 | n/a | 5 |
| Sep ’25 | HK$1.04 | HK$1.27 +22.5% | 20.5% | HK$1.79 | HK$1.10 | n/a | 5 |
| Aug ’25 | HK$1.08 | HK$1.31 +21.0% | 23.4% | HK$1.91 | HK$1.09 | n/a | 5 |
| Jul ’25 | HK$1.10 | HK$1.45 +32.2% | 29.6% | HK$2.19 | HK$1.10 | n/a | 6 |
| Jun ’25 | HK$1.13 | HK$1.46 +28.8% | 29.7% | HK$2.19 | HK$1.10 | n/a | 6 |
| May ’25 | HK$1.11 | HK$1.44 +30.0% | 28.1% | HK$2.20 | HK$1.09 | n/a | 7 |
| Apr ’25 | HK$1.03 | HK$1.44 +40.0% | 28.0% | HK$2.19 | HK$1.09 | n/a | 7 |
| Mar ’25 | HK$1.12 | HK$1.52 +35.5% | 28.5% | HK$2.20 | HK$1.09 | n/a | 6 |
| Feb ’25 | HK$1.05 | HK$1.52 +44.9% | 28.4% | HK$2.20 | HK$1.09 | n/a | 6 |
| Jan ’25 | HK$1.13 | HK$1.52 +34.6% | 28.4% | HK$2.20 | HK$1.09 | n/a | 6 |
| Dec ’24 | HK$1.12 | HK$1.63 +45.6% | 25.7% | HK$2.21 | HK$1.22 | n/a | 5 |
| Nov ’24 | HK$1.06 | HK$1.59 +50.3% | 25.8% | HK$2.16 | HK$1.17 | HK$1.21 | 5 |
| Oct ’24 | HK$1.11 | HK$1.59 +43.5% | 24.4% | HK$2.17 | HK$1.18 | HK$1.20 | 6 |
| Sep ’24 | HK$1.10 | HK$1.54 +40.2% | 25.1% | HK$2.18 | HK$1.18 | HK$1.04 | 7 |
| Aug ’24 | HK$1.19 | HK$1.62 +36.2% | 23.3% | HK$2.20 | HK$1.19 | HK$1.08 | 7 |
| Jul ’24 | HK$1.23 | HK$1.64 +33.3% | 20.0% | HK$2.19 | HK$1.28 | HK$1.10 | 7 |
| Jun ’24 | HK$1.26 | HK$1.65 +31.3% | 20.6% | HK$2.22 | HK$1.30 | HK$1.13 | 7 |
| May ’24 | HK$1.37 | HK$1.63 +18.8% | 26.6% | HK$2.27 | HK$0.90 | HK$1.11 | 7 |
| Apr ’24 | HK$1.37 | HK$1.66 +20.9% | 26.5% | HK$2.30 | HK$0.92 | HK$1.03 | 7 |
| Mar ’24 | HK$1.37 | HK$1.66 +20.8% | 24.0% | HK$2.18 | HK$0.90 | HK$1.12 | 7 |
| Feb ’24 | HK$1.46 | HK$1.64 +12.1% | 29.5% | HK$2.23 | HK$0.91 | HK$1.05 | 7 |
| Jan ’24 | HK$1.32 | HK$1.59 +20.2% | 29.7% | HK$2.15 | HK$0.88 | HK$1.13 | 7 |
| Dec ’23 | HK$1.25 | HK$1.51 +20.8% | 30.9% | HK$2.10 | HK$0.86 | HK$1.12 | 7 |
| Nov ’23 | HK$1.05 | HK$1.51 +43.8% | 30.9% | HK$2.10 | HK$0.86 | HK$1.06 | 7 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Aluminum Corporation of China
HK$125.2b
Primarily engages in the exploration and mining of bauxite, coal, and other resources in the People's Republic of China and internationally.
2600
HK$4.69
7D
-4.1%
1Y
21.5%
Jiangxi Copper
HK$63.4b
Engages in exploring, mining, ore dressing, smelting, refining, and processing of copper in Mainland China, Hong Kong, and internationally.
358
HK$12.48
7D
-1.0%
1Y
13.9%
Aluminum Corporation of China
HK$125.3b
Primarily engages in the exploration and mining of bauxite, coal, and other resources in the People's Republic of China and internationally.
2600
HK$4.62
7D
-2.3%
1Y
20.9%